Spinol Medical Advances OctaSeal into FDA Review

Spinol Medical marked the advancement of the OctaSeal Annular Closure System into FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close annular defects following lumbar discectomy. Delivered through a 5mm minimally invasive working channel, the implant expands within the disc space to create a stable, tissue-preserving, motion preserving repair.

OctaSeal is not available for sale in the U.S., where there is only one annular closure device currently on the market, leaving whitespace for novel technologies that preserve anatomy, reduce re-herniation, and avoid escalation to more invasive procedures.

OctaSeal offers a combination of intradiscal, anatomic placement and tubular-based insertion, avoiding the need for bone removal, defect widening, or additional nerve retraction. The implant self-deploys within the disc space and engages the endplates through eight low-profile anchoring surfaces.

Key Technology Attributes

• Micro-invasive, 5mm tube-based insertion
• Intradiscal, anatomical placement
• Self-deploying architecture; Single-Step, Single Instrument
• Preserves native tissue and surgical corridor, Outpatient & ASC Friendly
• Compatible with any microdiscectomy and endoscopic workflows
• Single use, pre-sterile kit

By preserving anatomy and simplifying technique, OctaSeal is designed to help prevent re-herniation and reduce progression to more invasive surgical interventions.

Michael S. Butler, Executive Chairman of Spinol Medical, commented, “Advancing OctaSeal into FDA review represents a significant inflection point, not just for Spinol, but for a market that has been underserved for decades. With only one competitor in a multi-billion-dollar category, the opportunity to deliver a novel, minimally invasive solution supported by five-year data is extraordinary. OctaSeal’s intradiscal, tissue-preserving approach is designed to reduce unnecessary anatomical disruption, which may help keep patients from progressing to larger, more invasive surgeries. We believe this is the type of elegant design that can shift a standard of care.”

Source: Spinol Medical